Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
500 µg/mL
Hemolytic
Cytotoxic
50% Hemolysis | 500 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Short bioactive peptides | PATENT US 6875744B2 | 2005